KLRK1 and neoplasm: The latter effect could be relevant in an in vivo setting, complementing the NKG2D-CAR- and NKAB-mediated cytotoxicity of IL-15-producing NKAR-NK-92 cells by also enhancing the antitumor activity of endogenous immune cells in the tumor microenvironment.